16 February, 2013 Saudi Heart Association
11:00-11:15
The Great Debate: All multivessel CAD in 2013 should undergo multivessel PCI: Con
Abdullah A. Alghamdi, MD, MSc, FRCSC
1
Disclosure
• I have no relations with pharmaceutical or device companies • I have no conflict of interest to disclose
2
Multivessel PCI Should NOT be done for all patients
• PCI should not be done for all patients with multivessel CAD due to the presence of a superior and Gold Standard treatment strategy “CABG” • Specific Reasons will be discussed below:
3
Reason 1
Heart Heart Team Team Approach Approach & & Practice Practice Guidelines Guidelines
4
State of the art clinical practice
5
Sate of the art clinical practice
Isaac Elzevir , 1620 6
The Practice of Teamwork (Multidisciplinary Approach)
• State of art approach for best practice • Platform to offer a tailored treatment strategy for specific patient • Supported by guidelines
7
Heart Team Approach
• Class Ic in American & European Guidelines • Reports have shown that survival was better in patient discussed as opposed to randomized • Syntax score and STS scores are useful measures • FAME Trial 8
Multivessel CAD
9
Practice Guidelines
• Provide the best available advice for use by most practitioners • Task forces, committees • Experts in field • Balanced and scientific literature reading and synthesis • Interventional cardiologists and cardiac surgeons 10
Guidelines
11
Guidelines
12
Guidelines
13
Guidelines
14
Guidelines
15
Reason 2
Failure Failure of of revascularization revascularization (need (need for for intervention) intervention) isis more more in in PCI PCI than than CABG CABG
16
Failure of Revascularization
• Graft Patency: 5, 10 and 15 years • IMA: 98%, 95%, 88% • SVG: 80%, 60%, 50% Worst conduit is better than any stent, and that was before the advanced antiplatelet and statin therapy Tatoulis J, Ann Thorac Surg. 2004;77(1):93. Sabik JF 3rd, Ann Thorac Surg. 2005;79(2):544
17
Failure of Revascularization
• Observational and RCTs showed overwhelming evidence that PCI is inferior with regard to repeat revascularization (failure of initial revascularization) • PCI has high rate of failure
18
Failure of Revascularization
Davide C, J Am Col Cardiol, 58-14, 2011.
19
Failure of Revascularization
20
Reason 3
PCI PCI results results in in more more cardiac cardiac death death than than CABG CABG
21
Cardiac Death
22
Reason 4
PCI PCI results results in in more more MI MI than than CABG CABG
23
Myocardial Infarction
24
Reason 5
CABG CABG isis the the best best strategy strategy for for diabetic diabetic patients patients
25
Multivessel disease in Diabetic Patients
• Conservative figures showed at least 25% of those undergoing revascularization are diabetics
FREEDOM Trial, NEJM, 2012 26
Multivessel disease in Diabetic Patients
JACC Vol. 58, No. 24, 2011 27
Multivessel disease in Diabetic Patients
FREEDOM Trial, NEJM, 2012 28
Multivessel disease in Diabetic Patients
FREEDOM Trial, NEJM, 2012 29
Multivessel disease in Diabetic Patients
FREEDOM Trial, NEJM, 2012 30
Reason 6
Complete Complete Revascularization Revascularization
31
Complete Revascularization
• CABG offers complete or near complete revascularization • PCI does not offer complete revascularization in all patients (~ 70%) • Those with incomplete revascularization had trends for higher mortality and significantly needed reinterventions Jones EL, Am J Cardiol. 1983;51:7–12. Bell MR, J Am Coll Cardiol. 1990;16:553– 62. Bourassa MG, Eur Heart J. 1998;19:103–11. Faxon DP, Am Heart J. 1992;123:854 –9. 32
Reason 7
PCI PCI requires requires the the use use of of DAPT: DAPT: Expensive, Expensive, Needs Needs Compliance Compliance
33
DAPT use
• PCI requires the use of DAPT • Plavix is relatively expensive • Noncompliance or inability to afford results is stent thrombosis (20-45% mortality)
Grines CL, J Am Coll Cardiol.2007;6:734 –9.
34
Reason 8
CABG: CABG: Real Real World World Results Results
35
Real World Results
16% 21% • • • • •
>65 year ≥ 2VD Not ACS CABG=86,244 PCI=103,549
William Weintraub, NEJM, 2012 36
Reason 9
PCI PCI isis only only suitable suitable for for subgroup subgroup of of patients patients with with multivessel multivessel disease disease
37
Extent of CAD
38
Extent of CAD
39
Extent of CAD
40
Reason 10
PCI PCI isis not not suitable suitable for for all all patients patients with with multivessel multivessel CAD CAD
41
Patients with multivessel CAD CABG
25% DM
Complete revascula rization
Concomitant valvular
PCI
5% LM
Issues with Plavix
Proximal LAD
Complex CAD 5% CKD
Poor LVF
Patient Choice
Patient Choice
Comrobid Less complex CAD
42
Summary
43
Embolic Load During Diagnostic Angiography
Emboli were detected in about 15%
Cluster of microemboli entering MCA Eur Heart J. 2005 Jul;26(13):1269-75 44
Embolic Load During Diagnostic Angiography
Int. J Cardiol 2009 45
PRECOMBAT Trial
N Engl J Med. 2011 May 5;364(18):1718-27 46
SYNTAX results in 5- year
47
Surgical Approach to reduce CVA
• Neurocognitive function is comparable to PCI (BARI/SOS) • Emboli come from aorta due to manipulation (X-Clamp/Cardioplegia) • Adoption of aortic no touch techniques minimizes the risk of stroke in first year
48
Surgical Approach to reduce CVA
Ann Thorac Surg. 2010 Oct;90(4):1384-90 49
Cost Effectiveness
• Cost effectiveness analysis: Quality Adjusted Life Year • Magnuson reported the cost effectiveness of CABG vs PCI in Freedom Trial • of CABG surgery was reported at $34 467 while the cost of PCI was $24 845 • At follow up CABG was cost-effective with an incremental cost-effectiveness ratio of $8132 per QALY gained Freedom Trial 50